Study | Acute phase | Sex (M/F) | Age | Experimental group | Control group | Course | Outcomes | ADRs/ADEs | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N | T1 | Dosage | N | T2 | Dosage | |||||||
Yu YC 2014 | 72 h | 38/30 | 62.5 (44–76) | 34 | XST1 | 500 mg | 34 | AADN | – | 14d | (1) | None |
Yu YM 2009 | 72 h | 71/45 | 62.5 (40–72) | 58 | DH | 20 ml | 58 | FFDS | 20 ml | 15d | (1)(2) | Unclear |
Yu Y 2015 | 72 h | 35/21 | 54.3 (38–71) | 28 | XST1 | 500 mg | 28 | FFDS | 20 ml | 14d | (1)(2) | 6 |
Zhang ZJ 2008 | 74Â h | 41/30 | 64.3 | 35 | SX | 100Â ml | 36 | FFDS | 20Â ml | 14d | (1) | None |
Zheng XD 2007 | 72Â h | 39/21 | 66.4 | 30 | YXDM | 20Â mL | 30 | FFDS | 30Â ml | 14d | (1) | None |
Zhou SJ 2011 | 1 M | 46/34 | 62 (42–75) | 40 | SX | 100 ml | 40 | AADN | – | 14d | (1)(2) | None |
Zhou SF 2009 | 48 h | 52/42 | 65.6 (62–86) | 48 | SX | 200 ml | 46 | FFDS | 20 mL | 21d | (1)(2) | 10 |
Zhou SH 2013 | 72 h | 50/40 | 62 | 45 | SXN | 20 ml | 45 | AADN | – | 14d | (1)(4) | None |
Xu XY 2011 | 12 h | 40/20 | 55.9 (45–73) | 30 | YXDM | 20 ml | 30 | DS | 20 ml | 21d | (1)(2)(3) | Unclear |
Xie S 2011 | 24 h | 42/30 | 61.4 (53–78) | 36 | SXT | 6 ml | 36 | FFDS | 20 ml | 14d | (1) | None |
Xie YG 2010 | 48 h | 39/31 | 61.6 (50–76) | 35 | SXT | 6 ml | 35 | DZHS | 50 mg | 14d | (1)(2) | None |
Xu LL 2011 | 72 h | 48/34 | 63.0 (55–81) | 42 | LI | 120 mg | 42 | AADN | – | 14d | (1)(2) | Unclear |
Xu XQ 2012 | 72Â h | 64/44 | 57.9 | 54 | YXDM | 20Â ml | 54 | FFDS | 20Â ml | 14d | (1)(2) | 1 |
Yang HJ 2007 | 24 h | 50/34 | 53.6 (39–75) | 48 | DSCXQ | 10 ml | 36 | FFDS | 10 ml | 30d | (1)(2) | 1 |
Yang YF 2012 | 48 h | – | 68 | 112 | DH | 30 ml | 101 | AADN | – | 21d | (1)(2) | Unclear |
Yao QY 2010 | 72 h | 64/40 | 70.8 (54–82) | 56 | SXT | 6 ml | 48 | LI | 12 ml | 14d | (1)(2) | 2 |
Yao J 2010 | 72 h | 37/27 | 60.5 (49–76) | 32 | YXDM | 20 ml | 32 | DZHS | 50 mg | 14d | (1)(2) | None |
Xie RP 2010 | 72 h | 52/28 | 42–80 | 40 | SXN | 20 ml | 40 | FFDS | 20 mL | 15d | (1) | None |
Tan SY 2016 | 72 h | 49/37 | 39–82 | 43 | DH | 30 ml | 43 | AADN | – | 14d | (1)(2) | None |
Wang WP 2015 | 72 h | 49/41 | 68.2 (60–78) | 45 | SXN | 20 mL | 45 | FFDS | 20 mL | 14d | (1)(2) | Unclear |
Ren HM 2009 | 72 h | 38/26 | 40–78 | 32 | SX | 100 ml | 32 | AADN | – | 14d | (1)(2) | None |
Sun HJ 2013 | 72 h | 42/36 | 60.9 (40–70) | 39 | LI | 120 mg | 39 | AADN | – | 14d | (1)(2) | Unclear |
Tang JP 2013 | 72 h | 47/45 | 51.8 (43–73) | 46 | HHHSS | 100 mg | 46 | AADN | – | 14d | (1)(2) | None |
Tang FY 2009 | 72 h | 39/33 | 64.0 (50–78) | 36 | DZHS | 50 mg | 36 | AADN | – | 14d | (1)(2) | None |
Tang XJ 2013 | 72 h | 45/33 | 58 | 39 | YXDM | 20 mg | 39 | AADN | – | 14d | (1)(2) | None |
Wang L 2010 | 48 h | 26/22 | 65.6 (62–86) | 40 | SX | 200 mL | 40 | FFDS | 20 mL | 21d | (1)(2) | Unclear |
Wang YL 2013 | 168 h | 33/23 | 32–88 | 28 | SXT | 6 ml | 28 | DZHS | 40 ml | 14d | (2) | Unclear |
Lan Y 2015 | 72 h | 41/39 | 54–72 | 40 | DSCXQ | 10 ml | 40 | AADN | – | 14d | (1)(2) | 3 |
Li M 2014 | 24 h | 63/17 | 48–76 | 40 | DH | 30 ml | 40 | AADN | – | 14d | (2) | Unclear |
Liu YP 2010 | 72 h | 45/35 | 51–71 | 40 | DH | 40 ml | 40 | AADN | – | 15d | (1) | 1 |
Ma J 2010 | 24 h | 29/31 | 59.1 (50–68) | 30 | DZHS | 20 mg | 30 | AADN | – | 14d | (1)(2) | Unclear |
Ma J 2015 | 72 h | 49/41 | 65.5 (45–79) | 45 | DH | 20 ml | 45 | AADN | – | 28d | (1)(4) | Unclear |
Chen H 2015 | 24 h | 74/60 | 59.4 (46–87) | 67 | SXT | 6 ml | 67 | AADN | – | 14d | (1)(2) | 5 |
Luan T 2014 | 48Â h | 52/43 | 57.5 | 50 | XST2 | 0.4Â g | 45 | DS | 20Â ml | 15d | (1)(4) | 7 |
Huang ML 2012 | 72 h | 158/142 | 62.6 (42–71) | 150 | XST1 | 500 mg | 150 | DS | 25 ml | 14d | (1) | 1 |
Li X 2015 | 72 h | 129/71 | 62.9 | 100 | HHHSS | 0.1 g | 100 | AADN | – | 14d | (1)(2) | Unclear |
Ma ZL 2011 | 72 h | 74/46 | 62.8 (45–84) | 60 | HHHSS | 0.1 g | 60 | AADN | – | 14d | (1)(2) | None |
Zhang Y 2012 | 48 h | 52/28 | 57.5 (35–80) | 40 | DSCXQ | 100 mg | 40 | AADN | – | 14d | (1)(2) | 1 |
Liu M 2014 | 48 h | 79/57 | 60.2 (40–76) | 68 | DSCXQ | 10 mL | 68 | AADN | – | 14d | (1)(2) | 2 |
Chen YC 2011 | 72Â h | 44/24 | 57.9 | 34 | YXDM | 20Â ml | 34 | FFDS | 20Â ml | 14d | (1)(2) | 1 |
Yang RF 2013 | 48 h | 52/48 | 60.8 (30–83) | 50 | SXT | 6 g | 50 | AADN | – | 14d | (1) | Unclear |
Lin YF 2008 | 72Â h | 39/21 | 66.5 | 30 | YXDM | 20Â ml | 30 | FFDS | 20Â ml | 14d | (1)(3) | None |
Peng T 2006 | 48Â h | 51/48 | 68 | 49 | SXT | 7Â ml | 50 | FFDS | 20Â ml | 14d | (1)(3) | 1 |
Li XH 2011 | 168 h | – | 63.5(40–78) | 120 | SXN | 20 ml | 120 | AADN | – | 14d | (1)(2) | Unclear |
Liu L 2015 | 6-72 h | 74/46 | 61.4 (39–76) | 60 | DH | 20 ml | 60 | SXN | 20 ml | 14d | (1) | None |
Zhang YH 2010 | 6-72 h | 62/34 | 58.9 (39–81) | 48 | DH | 30 ml | 48 | XST2 | 400 mg | 14d | (1)(2) | 5 |
Fan J 2006 | 72 h | 56/32 | 64 (41–82) | 44 | YXDM | 20 ml | 44 | FFDS | 20 ml | 14d | (2) | Unclear |
Liu HY 2014 | 96 h | 67/57 | 61.9 (38–83) | 64 | XST2 | 0.4 g | 60 | FFDS | 30 ml | 15d | (1) | None |
Li FQ 2010 | 72Â h | 74/46 | 64 | 60 | YXDM | 30Â ml | 60 | FFDS | 40Â ml | 15d | (1) | Unclear |
Lian CL 2013 | 360 h | 49/43 | 62 (43–77) | 46 | LI | 120 mg | 46 | AADN | – | 30d | (1) | None |
Chen S 2006 | 72Â h | 81/53 | 67.9 | 70 | XST2 | 800Â mg | 64 | XST1 | 10Â ml | 14d | (1)(2) | None |
Cao LZ 2012 | 72Â h | 71/9 | 59.3 | 40 | XST2 | 500Â mg | 40 | FFDS | 1.0Â g | 14d | (1)(2) | Unclear |
Liu Y 2009 | 72 h | 79/43 | 65.1 (43–73) | 62 | SXT | 6 ml | 60 | XST2 | 8 ml | 14d | (1) | 1 |
Luo XD 2011 | 72 h | 35/25 | 61.8 | 30 | XST2 | 0.4 g | 30 | AADN | – | 14d | (1)(2) | 3 |
Liao MJ 2014 | 6-72 h | 43/17 | 62.5 (36–80) | 30 | HHHSS | 100 ml | 30 | XST2 | 400 mg | 14d | (1) | Unclear |
Shi JL 2010 | 72Â h | 51/33 | 62 | 42 | YXDM | 20Â ml | 42 | LI | 200Â mg | 30d | (2) | Unclear |
Ni H 2010 | 24 h | 61/55 | 62.7 (54–74) | 59 | SXN | 20 ml | 57 | AADN | – | 14d | (1) | Unclear |
Li CP 2007 | 8-72 h | 106/54 | 63.8 (42–85) | 80 | SXN | 10-20 ml | 80 | AADN | – | 14d | (1) | Unclear |
Zhou ZP 2011 | 24 h | 48/33 | 62.2 | 42 | DZXX | 30 ml | 39 | AADN | – | 15d | (1) | Unclear |
Chen C 2015 | 72Â h | 37/31 | 67.5 | 34 | SXT | 6Â ml | 34 | XST2 | 400Â mg | 14d | (1)(2) | 14 |
Chen JY 2012 | 72 h | 73/35 | 67 (40–76) | 54 | SXT | 6 ml | 54 | FFDS | 20 ml | 14d | (1)(2) | Unclear |
Luo QY 2007 | 72 h | 54/36 | 63.6 (37–81) | 45 | SXN | 6 ml | 45 | AADN | 20 ml | 14d | (1) | None |
Chen J 2007 | 72Â h | 45/35 | 61 | 40 | YXDM | 20Â ml | 40 | MLN | 20Â ml | 15d | (1)(2)(3) | Unclear |
Zhang XL 2005 | 6d | 37/13 | 35–80 | 26 | MLN | 20 ml | 24 | FFDS | 20 m l | 21d | (2) | None |